NEW YORK, Dec. 5, 2017 /PRNewswire/ -- DelveInsight's "Pulmonary Arterial Hypertension - Market Insights, Epidemiology and Market Forecast 2027" report provides an overview of the disease and in depth research related to Pulmonary Arterial Hypertension for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2016-2027.
Read the full report: https://www.reportlinker.com/p04985957Pulmonary Arterial Hypertension (PAH), [WHO Class I] is a rare, chronic, and progressive form of Pulmonary Hypertension, which is characterized by the elevated pulmonary arterial
pressure (PAP) and pulmonary vascular resistance (PVR) in blood vessels carrying the blood from right side of heart through lungs. It occurs due to the tightening and stiffening of the small pulmonary arteries leading to the right ventricular dysfunction and vessel obstruction.Prevalence of PAH varies according to the geographical distribution, environmental factors, sex, age and socioeconomic factors. Despite the advancement and improvement in treatment owing to the unmet need of Pulmonary Arterial Hypertension the number of patients suffering from this rare disease is constantly increasing over the years. Amongst the major sub-types of PAH i.e., Idiopathic PAH, heritable PAH, and disease associated PAH, atleast more than 30% prevalent population suffers from idiopathic PAH. Unlike the previous studies, which underestimated the prevalence of PAH, the latest research findings have exhibited significant increment in the patient population, almost in tunes of approximately 70,000 patients in the 7MM. It was estimated that United States has higher prevalence of PAH as compared to EU5 and Japan. Among the EU5 countries, Germany accounts for the highest prevalence of PAH whereas Spain accounts for the lowest prevalence of PAH.This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Pulmonary Arterial Hypertension. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Pulmonary Arterial Hypertension for 7 major markets.According to DelveInsight, the forecasted patient population of Pulmonary Arterial Hypertension for the year 2025 will be XX, increasing at a CAGR of XX% from 2016 to 2027. The Global Market Size of PAH was found to be USD 5.13 Billion in 2016 and 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Pulmonary Arterial Hypertension market from inside out, with transparency into the calculated patient forecasting data and estimated market size.The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Pulmonary Arterial Hypertension market, as well as treatment algorithm, current treatments & advancements are included. The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Pulmonary Arterial Hypertension , providing an in-depth analysis of emerging therapies which will create an impact through their launch.Key Coverage Understanding historical and forecasted epidemiological data for Pulmonary Arterial Hypertension covering 7MM from 2016-2027. Segment level epidemiology and market split for Pulmonary Arterial Hypertension. The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Pulmonary Arterial Hypertension. The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2016-2027 and detailed historical and forecasted Pulmonary Arterial Hypertension market trends. Thorough market distribution based on market share for Pulmonary Arterial Hypertension.Reasons to buy The report will help in developing business strategies by understanding trends shaping and driving the Pulmonary Arterial Hypertension market. To understand the future market competition in the Pulmonary Arterial Hypertension market and Insightful review of the key market drivers and barriers. Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.Read the full report: https://www.reportlinker.com/p04985957 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/pulmonary-arterial-hypertension---market-insights-epidemiology-and-market-forecast---2027-300567388.html